Safety and Efficacy of Dexamethasone Intravitreal Implant Given Either First-Line or Second-Line in Diabetic Macular Edema

Andrea Taloni, Giulia Coco, Davide Rastelli, Giacinta Buffon, Vincenzo Scorcia, Giuseppe Giannaccare · 2023

Read Safety and Efficacy of Dexamethasone Intravitreal Implant Given Either First-Line or Second-Line in Diabetic Macular Edema by Andrea Taloni, Giulia Coco, Davide Rastelli, Giacinta Buffon, Vincenzo Scorcia, Giuseppe Giannaccare (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10725633.txt.

Description

Andrea Taloni and co-authors review a steroid eye implant for diabetic swelling in a 2023 paper. Fluid in the central retina is a top cause of vision loss in working-age diabetics. The slow-release dexamethasone implant calms inflammation and lasts longer than standard injections, but it can raise eye pressure and cloud the lens.

The review weighs when to use it first: patients who cannot take the standard drugs, eyes with strong inflammation signs, eyes with artificial lenses, and eyes after vitrectomy. Switching non-responders and combining therapies also feature. Readers get a placement guide for this implant.

Catalog record

CREATORAndrea Taloni, Giulia Coco, Davide Rastelli, Giacinta Buffon, Vincenzo Scorcia, Giuseppe Giannaccare
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE57 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10725633

Browse the full library · About the Tower of Babel